Details of the Drug Reposition

General Information of This Drug (ID: DM2VDUE)

Drug Name	BIOD-123 DM2VDUE

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Type-1 diabetes	DIS7HLUB	5A10	Phase 2	[1]
Type-2 diabetes	DIS3X247	5A11	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01686620) A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog). U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)